6. Opportunities LSH sector in Turkey
Transformation of Healthcare program
(2003>); substantial reshuffle of the
whole sector focused on more efficiency
and improved access, such as:
Improving access to all target groups
Increasing health insurance coverage
Stimulating ehealth
Local production of drugs
Tax favorable regimes for pharma
industry (spearhead industry)
AiFD, Association of Research-based
pharmaceutical companies
Health tourism: in 2010 ~0,5 million
foreigners treated
7. Opportunities LSH sector in Turkey
Modernising and building new hospitals (Health campuses with huge
investments in more than 20 cities)
8. Opportunities LSH sector in Turkey
85% of medical instruments are imported; Turkey harmonises its
market to the EU; around 1000 local producers cover ~ 15% of the
demand
Local production has low added value; need for more high value
added production
Ehealth to digitise hospitals and empower citizens through smart
phones
Growth of Tele-medicine
Turkey wants to stimulate local medicine production
9. Burden of health expenditure on citizens' shoulder grows
Spending on health care by citizens has increased from TL 8.1 billion to
TL 14 billion since 2009 and is expected to reach TL 15 billion by the end
of the year. (Today’s Zaman, 25-10-2014)
10. Average body weight in Turkey increases by 2.2 kilos in 5 years
(Today’s Zaman, 24-10-2014)
11. TNO in Turkey so far
Good contacts with:
Ministry of Labour; TNO contributed to new OSH Act in
Turkey
Ministry of Health on obesity
Dutch embassy
MESS, metal employer’s organisation
Others with potential leads
Project funded through MESS, FERROSH
Realised network obesity prevention with Turkish members
Local partners: Veslabs and PM Group Ankara
Support of local liaison officer: Mrs. Sühendan Adigüzel-van
Zoelen
12. Diversified approach Healthy Living
Public sector:
national (ministries),
regional (Ankara regional development agency),
municipalities
Private sector
Food sector
Pharma sector
Competitive research funding
HORIZON 2020 Turkish partners
IPA tenders Turkish partners
Jan Michiel Meeuwsen
OSH in Dutch SME's
13. Competitive research funding
Stakeholders:
TUBITAK
Universities
Consultancy firms
TNO portfolio: experience in EU competitive funding, vast area of
research areas
Approach: contact and MOU (Memorandum of Understanding) with
TUBITAK, universities, partnering with local Turkish consultancy firms,
personal follow up liaison officer
Jan Michiel Meeuwsen
OSH in Dutch SME's
14. Some examples of R&D collaboration
ERA-IB: European Research Area
Industrial Biotechnology; TNO partnered
with Turkish SME H2biyotek
FP7 project aiming to achieve maximised
resource productivity and recycling and re-
use of valuable materials, RESFOOD;
TNO partnered with Turkish TÜBİTAK
Marmara Research Center and Arısu Gıda
Dış Tic. A.Ş.
In development: Igrow, obesity prevention
app on the Turkish market with Veslabs